Sun Pharmaceutical Industries Ltd Sees Surge with 7,050 Call Contracts at Rs 1,600 Strike

Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in today's trading session, particularly in the options market. The company, operating within the Pharmaceuticals & Biotechnology sector, has seen significant activity in call options with an expiry date set for September 30, 2025. Notably, 7,050 contracts were traded at a strike price of Rs 1,600, resulting in a turnover of Rs 751.107 lakhs. The underlying value of the stock is currently at Rs 1,596.6, which places it just 2.69% away from its 52-week low of Rs 1,553.05.
In terms of performance, Sun Pharma has been gaining traction over the past three days, with a modest return of 0.95% during this period. The stock's performance today aligns closely with the sector, which recorded a 0.03% return. Additionally, the stock is trading above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed short to medium-term trends.

Investor participation has also seen a notable increase, with delivery volume rising by 35.96% compared to the 5-day average, reaching 15.97 lakhs. The stock's liquidity remains robust, accommodating trade sizes of Rs 6.45 crore based on 2% of the 5-day average traded value. Overall, Sun Pharmaceutical Industries Ltd continues to attract attention in the market, reflecting its active trading status and underlying performance metrics.